Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Akebia completes enrollment in renal anemia trial - Seeking Alpha (registration) |
 |
 |
|
Seeking Alpha (registration) Akebia Therapeutics (NASDAQ:AKBA) completes patient enrollment in the third and final cohort in its Phase 2 study evaluating its lead product candidate, AKB-6548, for the treatment of patients with anemia secondary to chronic kidney disease (CKD) who ... Akebia Announces Completion of Enrollment in Phase 2 Trial of AKB-6548 in |
